Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

Sep 20, 2018 7:00 AM - Sep 21, 2018 12:45 PM

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Advancing the Science of Study Endpoints

Session 4: Regulatory Update

Session Chair(s)

Ashley F. Slagle, PhD, MS

Ashley F. Slagle, PhD, MS

Principal, Scientific and Regulatory Consulting

Aspen Consulting, LLC, United States

Hear timely updates from FDA representatives on the 21st Century Cures Act provision to expand the qualification and use of drug development tools (DDTs) to support the drug development process. Attendees will hear an update on FDA’s patient-focused drug development, including their thoughts on leveraging COAs in cancer clinical trials.

Speaker(s)

Paul  Kluetz, MD

Paul Kluetz, MD

FDA, United States

Deputy Director, Oncology Center of Excellence, OC

Elektra  Papadopoulos, MD, MPH

Elektra Papadopoulos, MD, MPH

AbbVie, United States

Director, Patient Experience Data and Strategy

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.